ENGINEERING EXTRACTED, ISOLATED, & PURIFIED BIOACTIVE METABOLITE-NANO CONJUGATES FOR ENHANCED ANTI-CANCER EFFICACY AND APOPTOSIS IN CANCER CELL LINES AND PATHWAY ANALYSIS VIA SYSTEM BIOLOGY BIS601

ASSESSMENT OF ROS GENERATION AND CELLULAR TOXICITY BY EXTRACTED, ISOLATED, & PURIFIED METABOLITE-NANOCONJUGATES IN NORMAL CELL LINES AND PATHWAY ANALYSIS VIA SYSTEM BIOLOGY BIS602

DEVELOPING AND CHARACTERIZING EXTRACTED, ISOLATED, & PURIFIED METABOLITE-NANOPARTICLE CONJUGATES TO INDUCE APOPTOSIS AND SUPPRESS BCL-2 IN CANCER CELL LINES AND PATHWAY ANALYSIS VIA SYSTEM BIOLOGY BIS603​
​
BIODEGRADATION OF PLASTICS USING MICROORGANISMS: ANALYSIS OF PETASE ENZYME ACTIVITY, PROTEIN COMPARISON, FTIR SPECTROSCOPY, AND GENETIC MODIFICATIONS BIS301
​
EVALUATION OF BLATEM GENE EXPRESSION IN GENETICALLY MODIFIED BACTERIA FOLLOWING MINIMUM INHIBITORY CONCENTRATION ANALYSIS OF WILD-TYPE AND GENETICALLY MODIFIED BACTERIA WITH CHITOSAN NANOPARTICLE-DRUG CONJUGATES, INCLUDING PHYLOGENETIC TREE ANALYSIS, DISTANCE MATRIX, MULTIPLE SEQUENCE ALIGNMENT, AND SEQUENCE SIMILARITY BIS302
​​
EXTRACTION, ISOLATION, AND PURIFICATION OF PURE METABOLITES AND THEIR CONJUGATION WITH POLYMER NANOPARTICLES TO ASSESS THE EFFICACY AGAINST POLYMICROBIAL SEPSIS IN MAMMALIAN SERUM (HOST-PATHOGEN INTERACTION) AND ANTI-CANCER ACTIVITY IN MDA MB-231 CELL LINES BIS303

TO ISOLATE & CHECK THE EFFICACY OF PURE METABOLITES CONJUGATED NANOPARTICLES IN SYSTEMS BIOLOGY, POLYMICROBIAL SEPSIS IN MAMMALIAN SERUM (HOST-PATHOGEN INTERACTION), ANTI-FUNGAL, ANTIOXIDANT & ANTI-COAGULANT ACTIVITY BIS304

EVALUATING THE ANTI-OXIDANT, ANTI-COAGULANT, ANTI-DIABETIC, AND ANTI-THYROID POTENTIAL OF EXTRACTED, ISOLATED, & PURIFIED METABOLITE-NANOCONJUGATES TO ANALYSE THE SIGNALLING PATHWAY VIA SYSTEM BIOLOGY BIS305
​
INTEGRATED OMICS-DRIVEN PIPELINE FOR NANOCOATED METABOLITE DISCOVERY AND GENOMIC VALIDATION IN DRUG DEVELOPMENT COVERING METABOLOMICS, GENOMICS & PROTEOMICS (a multidisciplinary approach to drug development, beginning with the selection of a plant, fungus, or bacterium for metabolite sourcing. Metabolites are finalised using databases like IMPAAT, KNApSAcK, PubChem, and MassBank within metabolomics, followed by drug likeness assessment via MolSoft. The drug is remodelled with nanocoating, and its nanoconjugate is docked, with toxicity evaluated using ProTox and details sourced from Swiss, STITCH, and SuperPred. Gene targets are identified using GeneCard and OMIM, with gene comparisons and common genes analysed using Venny. KEGG pathways are explored through ShinyGO. Gromacs simulations enhance structural insights, and genomics/proteomics analyses involve Fasta and BLAST of the modulating gene/protein. Further genomics steps include sequence similarity, multiple sequence alignment, diversity, ancestry, phylogenetic and BLAST tree construction, mutation diagnosis with primer design, and NGS data analysis of the source organism) BIS306

DEVELOPMENT OF NOOTROPIC FORMULATIONS WITH SUSTAINED RELEASE USING POLYMER NANOPARTICLES BIS151
​​
EXTRACTION, ISOLATION, AND PURIFICATION OF LIMONENE AND ITS CONJUGATION WITH POLYMER NANOPARTICLES TO EVALUATE EFFICACY AGAINST POLYMICROBIAL SEPSIS INFECTIONS BIS152
​​
COMPARATIVE ANALYSIS OF SHELF LIFE BETWEEN COMMERCIAL BAKED GOODS AND HOMEMADE ITEMS, HIGHLIGHTING THE ROLE OF ADDITIVES AND EMULSIFIERS IN COMMERCIAL PRODUCTS AND THEIR IMPACT ON GUT MICROBIOTA BIS153
​​
EXTRACTION, ISOLATION, AND PURIFICATION OF A SECONDARY METABOLITE AND ASSESSMENT OF ITS ANTIMICROBIAL ACTIVITY AGAINST BIOFILMS AND POLLUTED WATER BODIES CONTAMINATED BY DIVERSE BACTERIAL LOADS BIS154
​​
PRODUCTION OF BIOFERTILIZERS AND COMPARATIVE EVALUATION WITH SYNTHETIC FERTILIZERS ON THE ROLE OF PHYTOHORMONES IN PLANT GROWTH THROUGH IN-VITRO AND IN-VIVO TESTING BIS155
​​
COMPARATIVE STUDY OF SHELF LIFE BETWEEN COMMERCIAL AND HOMEMADE CANDIES, EMPHASIZING THE USE OF FOOD COLORING AGENTS IN COMMERCIAL PRODUCTS AND THEIR EFFECTS ON GUT MICROBIOTA BIS156
​​
DEVELOPMENT OF GENETICALLY MODIFIED PROBIOTIC-PREBIOTIC CONJUGATES WITH POLYMER NANOPARTICLES AND EVALUATION OF THEIR EFFICACY AGAINST GUT-BASED PATHOGENS BIS157
​​
PROTEIN EXPRESSION, ISOLATION, AND PURIFICATION FROM GENETICALLY MODIFIED MICROBES AND ASSESSMENT OF THEIR EFFICACY AGAINST PATHOGENIC CULTURES BIS158
​​
INVESTIGATION OF ANTIMICROBIAL RESISTANCE OF ARTIFICIAL PRESERVATIVES AND ADULTERANTS IN MILK BIS159
​​
UTILIZATION OF BACTERIAL PROTEINS AND BACTERIOCINS WITH NANOPARTICLE CONJUGATES IN THE INHIBITION OF BIOFILM-RELATED INFECTIONS BIS1510
​​
PREPARATION OF ORGANIC BIOPESTICIDES AND MICROBIAL BIOFERTILIZERS WITH IN-VITRO AND IN-VIVO TESTING BIS1511
​
ANTIMICROBIAL EFFICACY OF SILVER, COPPER, OR ZINC NANOPARTICLES AGAINST POLYMICROBIAL INFECTIONS BIS1512
 
DEVELOPMENT OF AN ANTISEPTIC SKIN OIL FORMULATION WITH EXTRACTED ISOLATED & PURIFIED METABOLITES CONJUGATED NANOPARTICLES AND ITS COMPARISON WITH A COMMERCIAL PRODUCT BIS1513

DISSOLUTION DYNAMICS AND QUALITY ASSURANCE: A COMPARATIVE QUALITY CONTROL ANALYSIS OF COMMERCIAL VS. SELF-SYNTHESISED PHARMACEUTICALS BIS1514
​
ISOLATION OF BIOACTIVE COMPOUNDS FROM PLANTS AND EVALUATION OF THEIR ANTIBIOFILM PROPERTIES BIS101
​​
DEVELOPMENT OF AN EFFECTIVE ORGANIC ORANGE-BASED HAND SANITIZER AGAINST ENVIRONMENTAL PATHOGENS BIS102
​​
ISOLATION AND CHARACTERIZATION OF CELLULASE FROM BACILLUS SUBTILIS BIS103

MICROBIAL CLASSIFICATION & CHARACTERIZATION OF DIFFERENT SOURCES OF WATER AND ITS PHYLOGENETIC TREE ANALYSIS BIS104

CHARACTERIZATION OF PATHOGENS FROM DIFFERENT SOIL SOURCES AND THEIR PHYLOGENETIC ANALYSIS BIS105
​​
EVALUATION OF THE BENEFICIAL EFFECTS OF PROBIOTICS AND PREBIOTICS AGAINST PATHOGENIC ENTEROBACTERIACEAE BIS106